Four mutations in the porphobilinogen deaminase gene in patients with acute intermittent porphyria. 1995

G Lundin, and J Hashemi, and Y Floderus, and S Thunell, and E Sagen, and A Laegreid, and W Wassif, and T Peters, and M Anvret
Department of Clinical Genetics/Molecular Medicine, Karolinska Hospital, Stockholm, Sweden.

We have detected four different mutations in the porphobilinogen deaminase (PBGD) gene in acute intermittent porphyria (AIP) families from England, Norway, and Sweden. A splicing mutation in the first position of intron 8 (Int8 + 1) was found in a family from England and a missense mutation in exon 12 (Glu250) was detected in a Norwegian family. Two mutations were identified in Swedish families, one splicing mutation in the first position of intron 3 (Int3 + 1) and one missense mutation in exon 8 (Pro119).

UI MeSH Term Description Entries
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D011163 Hydroxymethylbilane Synthase An enzyme that catalyzes the tetrapolymerization of the monopyrrole PORPHOBILINOGEN into the hydroxymethylbilane preuroporphyrinogen (UROPORPHYRINOGENS) in several discrete steps. It is the third enzyme in the 8-enzyme biosynthetic pathway of HEME. In humans, deficiency in this enzyme encoded by HMBS (or PBGD) gene results in a form of neurological porphyria (PORPHYRIA, ACUTE INTERMITTENT). This enzyme was formerly listed as EC 4.3.1.8 Porphobilinogen Ammonia-Lyase,Porphobilinogen Deaminase,Uroporphyrinogen I Synthase,Hydroxymethylbilane Synthetase,Pre-uroporphyrinogen Synthetase,Preuroporphyrinogen Synthetase,Ammonia-Lyase, Porphobilinogen,Deaminase, Porphobilinogen,Porphobilinogen Ammonia Lyase,Pre uroporphyrinogen Synthetase,Synthase, Hydroxymethylbilane,Synthase, Uroporphyrinogen I,Synthetase, Hydroxymethylbilane,Synthetase, Pre-uroporphyrinogen,Synthetase, Preuroporphyrinogen
D011164 Porphyrias A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues. Porphyria,Porphyrin Disorder,Disorder, Porphyrin,Disorders, Porphyrin,Porphyrin Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

G Lundin, and J Hashemi, and Y Floderus, and S Thunell, and E Sagen, and A Laegreid, and W Wassif, and T Peters, and M Anvret
January 2015, Advances in clinical and experimental medicine : official organ Wroclaw Medical University,
G Lundin, and J Hashemi, and Y Floderus, and S Thunell, and E Sagen, and A Laegreid, and W Wassif, and T Peters, and M Anvret
January 1996, Human heredity,
G Lundin, and J Hashemi, and Y Floderus, and S Thunell, and E Sagen, and A Laegreid, and W Wassif, and T Peters, and M Anvret
February 1995, Human molecular genetics,
G Lundin, and J Hashemi, and Y Floderus, and S Thunell, and E Sagen, and A Laegreid, and W Wassif, and T Peters, and M Anvret
October 1993, Human molecular genetics,
G Lundin, and J Hashemi, and Y Floderus, and S Thunell, and E Sagen, and A Laegreid, and W Wassif, and T Peters, and M Anvret
May 2001, Genetika,
G Lundin, and J Hashemi, and Y Floderus, and S Thunell, and E Sagen, and A Laegreid, and W Wassif, and T Peters, and M Anvret
November 1989, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie,
G Lundin, and J Hashemi, and Y Floderus, and S Thunell, and E Sagen, and A Laegreid, and W Wassif, and T Peters, and M Anvret
September 1997, Journal of internal medicine,
G Lundin, and J Hashemi, and Y Floderus, and S Thunell, and E Sagen, and A Laegreid, and W Wassif, and T Peters, and M Anvret
September 1987, Lancet (London, England),
G Lundin, and J Hashemi, and Y Floderus, and S Thunell, and E Sagen, and A Laegreid, and W Wassif, and T Peters, and M Anvret
November 1997, Genome research,
G Lundin, and J Hashemi, and Y Floderus, and S Thunell, and E Sagen, and A Laegreid, and W Wassif, and T Peters, and M Anvret
January 2002, Journal of clinical laboratory analysis,
Copied contents to your clipboard!